5th Street Advisors LLC Grows Stock Holdings in SPDR S&P Biotech ETF $XBI

5th Street Advisors LLC raised its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 18,072 shares of the exchange traded fund’s stock after purchasing an additional 882 shares during the period. SPDR S&P Biotech ETF accounts for approximately 0.7% of 5th Street Advisors LLC’s portfolio, making the stock its 26th largest holding. 5th Street Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,499,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. DHJJ Financial Advisors Ltd. acquired a new position in SPDR S&P Biotech ETF during the second quarter worth approximately $25,000. Provident Wealth Management LLC boosted its stake in shares of SPDR S&P Biotech ETF by 3,000.0% in the first quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock valued at $25,000 after purchasing an additional 300 shares during the period. Garrison Bradford & Associates Inc. purchased a new position in shares of SPDR S&P Biotech ETF in the first quarter valued at $39,000. Compass Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 46.0% during the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock valued at $51,000 after acquiring an additional 200 shares during the last quarter. Finally, Golden State Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock valued at $52,000 after acquiring an additional 319 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $108.37 on Thursday. The stock has a market capitalization of $6.45 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $108.62. The company’s fifty day moving average is $95.16 and its two-hundred day moving average is $86.21.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.